Clinical Trial From Microbion Corporation

Microbion Corporation Announces Initiation of Phase 1 Clinical Trial for Topical Treatment of Acute Skin and Skin Structure Infections

Microbion Corporation, a Montana-based pharmaceutical company focused on development of novel therapeutics for treatment of bacterial infections, announced today that it has initiated a Phase 1 clinical trial of the company’s lead topical anti-infective drug product.  The double-blind randomized, placebo controlled study is being conducted at clinical sites in the United Kingdom and will assess safety, tolerability, and pharmacokinetics.  Read the Article…